Dr. Dave Rabin

And we published a paper on, if anybody's interested in what does proper use mean, we published a paper in 2023,

And we published a paper on, if anybody's interested in what does proper use mean, we published a paper in 2023,

As a collaboration between some of my colleagues at psychedelic.support, which is a major psychedelic harm reduction service, they're amazing, and my nonprofit, the Board of Medicine, and our clinic to describe the evidence-based best practice gold standards for what proper use means based on the current evidence we have today.

As a collaboration between some of my colleagues at psychedelic.support, which is a major psychedelic harm reduction service, they're amazing, and my nonprofit, the Board of Medicine, and our clinic to describe the evidence-based best practice gold standards for what proper use means based on the current evidence we have today.

for the use of psychedelic assisted therapy and psychedelics in therapy. So that being said, ketamine probably works in depression for about 50% of people with just four doses or six doses without therapy, but the effects tend to not be long lasting. So the effects will fade if you don't do it with the talk therapy.

for the use of psychedelic assisted therapy and psychedelics in therapy. So that being said, ketamine probably works in depression for about 50% of people with just four doses or six doses without therapy, but the effects tend to not be long lasting. So the effects will fade if you don't do it with the talk therapy.

If you include the talk therapy as a core part of it, we see the benefits sustaining for extended periods of time, like months or years later, people are still feeling like themselves and not symptomatic. Whereas when you just deliver the medicine by itself, people tend to relapse and become symptomatic again within usually a year or two or less.

If you include the talk therapy as a core part of it, we see the benefits sustaining for extended periods of time, like months or years later, people are still feeling like themselves and not symptomatic. Whereas when you just deliver the medicine by itself, people tend to relapse and become symptomatic again within usually a year or two or less.

So that's kind of how we use ketamine as a medicine and it being the only legal psychedelic medicine we have access to right now nationwide.

So that's kind of how we use ketamine as a medicine and it being the only legal psychedelic medicine we have access to right now nationwide.

Well, I mean, that's all we have right now. MDMA therapy has been on the horizon of legalization for a very long time. It's been researched in quite rigorous trials for the last 30, 40 years. MDMA-assisted therapy probably has the most evidence behind it for any mental health indication and mostly being studied for PTSD. Extremely effective and safe and promising when used properly.

Well, I mean, that's all we have right now. MDMA therapy has been on the horizon of legalization for a very long time. It's been researched in quite rigorous trials for the last 30, 40 years. MDMA-assisted therapy probably has the most evidence behind it for any mental health indication and mostly being studied for PTSD. Extremely effective and safe and promising when used properly.

And then there's psilocybin for depression and treatment-resistant depression, which has very promising trials. Psilocybin is also being used for end-of-life care. People who have

And then there's psilocybin for depression and treatment-resistant depression, which has very promising trials. Psilocybin is also being used for end-of-life care. People who have

had severe terminal physical illnesses like cancer have had great responses to psilocybin even just one dose um then the others are like ibogaine iboga which is an african root plant that is being used for opioid addiction studies psilocybin is being used for cocaine and other addiction studies so way this is like if you think about it it's a way to what is what why do people addiction is really at the heart of this i'm an addiction trauma psychiatrist as my focus and

had severe terminal physical illnesses like cancer have had great responses to psilocybin even just one dose um then the others are like ibogaine iboga which is an african root plant that is being used for opioid addiction studies psilocybin is being used for cocaine and other addiction studies so way this is like if you think about it it's a way to what is what why do people addiction is really at the heart of this i'm an addiction trauma psychiatrist as my focus and

Psychedelic medicines are really interesting because they help people shift their perspective on why they use substances. People who are using substances addictively use them to numb or distract themselves from discomfort in the body, which is usually caused by unprocessed or unresolved trauma.

Psychedelic medicines are really interesting because they help people shift their perspective on why they use substances. People who are using substances addictively use them to numb or distract themselves from discomfort in the body, which is usually caused by unprocessed or unresolved trauma.

and feeling basically, and that unprocessed, unresolved trauma makes us feel ashamed and therefore afraid to be ourselves and be in our bodies. It makes our bodies feel like an unsafe place. So correct use of psychedelics within the psychotherapy

and feeling basically, and that unprocessed, unresolved trauma makes us feel ashamed and therefore afraid to be ourselves and be in our bodies. It makes our bodies feel like an unsafe place. So correct use of psychedelics within the psychotherapy